Source:http://linkedlifedata.com/resource/pubmed/id/20413285
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-7-15
|
pubmed:abstractText |
Clinical trials to evaluate patients affected by rare diseases are often hampered by the difficulty of recruiting a critical sample size. Registries for rare conditions are thus extremely powerful tools for overcoming recruitment problems. Here we present and discuss the international experience with alpha1-antitrypsin deficiency achieved by the Alpha One International Registry, and national experience obtained with a large series of patients with pulmonary alveolar proteinosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1532-3064
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
104 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S42-4
|
pubmed:meshHeading |
pubmed-meshheading:20413285-Clinical Trials as Topic,
pubmed-meshheading:20413285-Humans,
pubmed-meshheading:20413285-International Cooperation,
pubmed-meshheading:20413285-Patient Selection,
pubmed-meshheading:20413285-Pulmonary Alveolar Proteinosis,
pubmed-meshheading:20413285-Rare Diseases,
pubmed-meshheading:20413285-Registries,
pubmed-meshheading:20413285-alpha 1-Antitrypsin Deficiency
|
pubmed:year |
2010
|
pubmed:articleTitle |
The problems of clinical trials and registries in rare diseases.
|
pubmed:affiliation |
Clinica di Malattie dell'Apparato Respiratorio, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Via Golgi 19, 27100 Pavia, Italy. m.luisetti@smatteo.pv.it
|
pubmed:publicationType |
Journal Article
|